dinutuximab - CISMeF

Preferred Label : dinutuximab;

MeSH note : a human-mouse chimeric monoclonal antibody directed against disialoganglioside (GD2); used for treatment of refractory neuroblastoma & osteosarcoma; in phase I trial 6/98;

MeSH synonym : dinutuximab beta;

MeSH hyponym : APN311; MAb ch14.18; CH-14.18-UTC; CH-14.18; monoclonal antibody ch14.18; ch14.18 monoclonal antibody; CH14.18-UTC;

Is substance : O;

UNII : 7SQY4ZUD30;

Details

Origin ID

C112746;

UMLS CUI

C0281581;

ATC code(s)
- dinutuximab beta [ATC Code]
Currated CISMeF NLP mapping
- Dinutuximab [NCIt concept]
- Dinutuximab (substance) [SNOMED CT concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
Record concept(s)
- APN-311 [MeSH concept]
- ch14.18 [MeSH concept]
- dinutuximab [MeSH concept]
- unituxin [MeSH concept]
See also inter- (CISMeF)
- Product containing dinutuximab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Dinutuximab [NCIt concept]
- Dinutuximab (substance) [SNOMED CT concept]
- Product containing dinutuximab (medicinal product) [SNOMED CT concept]
- dinutuximab beta [ATC Code]
Validated automatic mappings to BTNT
- dinutuximab beta [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients